Literature DB >> 11447186

Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity.

T I Kim1, Y C Lee, K H Lee, J H Han, C Y Chon, Y M Moon, J K Kang, I S Park.   

Abstract

Helicobacter pylori and nonsteroidal anti-inflammatory drugs (NSAIDs) are two well-known important causative factors of gastric damage. While H. pylori increases apoptosis and the proliferation of gastric epithelial cells and is an important factor in peptic ulcer and gastric cancer, NSAIDs induce cell apoptosis and have antineoplastic effects. We investigated the effects of NSAIDs (a nonselective cyclooxygenase [COX] inhibitor [indomethacin] and a selective COX-2 inhibitor [NS-398]) on the apoptosis and proliferation of gastric epithelial cells and gastric inflammation in H. pylori-infected mice. C57BL/6 mice were sacrificed 8 weeks after H. pylori SS1 inoculation. Indomethacin (2 mg/kg) or NS-398 (10 mg/kg) was administered subcutaneously once daily for 10 days before sacrifice. The following were assessed: gastric inflammatory activity, gastric COX protein expression by Western blotting; gastric prostaglandin E(2) levels by enzyme immunoassay, apoptosis by terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling, and cell proliferation by Ki67 immunostaining. Compared to the controls, H. pylori infection and/or NSAID treatment increased COX-1 and COX-2 protein expression. Gastric prostaglandin E(2) levels, apoptotic index, cell proliferation index, neutrophil activity, and the degree of chronic inflammation were all increased by H. pylori infection, and these effects were significantly decreased by indomethacin treatment. However, NS-398 treatment after H. pylori infection did not induce a significant reduction, although it did result in a tendency to decrease. These results show that NSAIDs can reverse the increased apoptosis and proliferation of epithelial cells and inflammatory activity in the stomachs of H. pylori-infected mice and that, like COX-2 activation, COX-1 induction contributes to the change of gastric mucosal cell turnover and inflammation induced by H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447186      PMCID: PMC98600          DOI: 10.1128/IAI.69.8.5056-5063.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

Review 1.  Inhibition of cyclooxygenase: a novel approach to cancer prevention.

Authors:  K Subbaramaiah; D Zakim; B B Weksler; A J Dannenberg
Journal:  Proc Soc Exp Biol Med       Date:  1997-11

2.  Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial.

Authors:  D Y Graham; N M Agrawal; S H Roth
Journal:  Lancet       Date:  1988-12-03       Impact factor: 79.321

3.  Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis.

Authors:  S J Hessey; J Spencer; J I Wyatt; G Sobala; B J Rathbone; A T Axon; M F Dixon
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

4.  Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

Authors:  C Aalykke; J M Lauritsen; J Hallas; S Reinholdt; K Krogfelt; K Lauritsen
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

5.  A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain.

Authors:  A Lee; J O'Rourke; M C De Ungria; B Robertson; G Daskalopoulos; M F Dixon
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

Review 6.  Review article: Cellular markers in the gastric precancerous process.

Authors:  S F Moss
Journal:  Aliment Pharmacol Ther       Date:  1998-02       Impact factor: 8.171

7.  Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation.

Authors:  N Futaki; I Arai; Y Hamasaka; S Takahashi; S Higuchi; S Otomo
Journal:  J Pharm Pharmacol       Date:  1993-08       Impact factor: 3.765

8.  Do non-steroidal anti-inflammatory drugs have an effect on gastric cell turnover?

Authors:  S M Sant; R J Cahill; J Gilvarry; C A O'Morain
Journal:  Aliment Pharmacol Ther       Date:  1995-10       Impact factor: 8.171

9.  Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis.

Authors:  J Rudi; D Kuck; S Strand; A von Herbay; S M Mariani; P H Krammer; P R Galle; W Stremmel
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

10.  Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.

Authors:  G A Piazza; A L Rahm; M Krutzsch; G Sperl; N S Paranka; P H Gross; K Brendel; R W Burt; D S Alberts; R Pamukcu
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

View more
  12 in total

1.  Alcohol-induced gastritis prevents oral tolerance induction in mice.

Authors:  M C Andrade; J S Menezes; G D Cassali; O A Martins-Filho; D C Cara; A M C Faria
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

Review 2.  Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.

Authors:  Yun Dai; Wei-Hong Wang
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

Review 3.  H pylori and host interactions that influence pathogenesis.

Authors:  Ellen J Beswick; Giovanni Suarez; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

4.  Effect of ibuprofen on cyclooxygenase and nitric oxide synthase of gastric mucosa: correlation with endoscopic lesions and adverse reactions.

Authors:  Sonia Gallego-Sandín; Jesús Novalbos; Aránzazu Rosado; Javier P Gisbert; María-Angeles Gálvez-Múgica; Antonio G García; José María Pajares; Francisco Abad-Santos
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

5.  Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.

Authors:  Chung-Wei Lee; Barry Rickman; Arlin B Rogers; Sureshkumar Muthupalani; Shigeo Takaishi; Peiying Yang; Timothy C Wang; James G Fox
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

6.  Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice.

Authors:  Hiroko Oshima; Masanobu Oshima; Kayo Inaba; Makoto M Taketo
Journal:  EMBO J       Date:  2004-03-11       Impact factor: 11.598

7.  Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis.

Authors:  Fang Yan; Hanwei Cao; Rupesh Chaturvedi; Uma Krishna; Stuart S Hobbs; Peter J Dempsey; Richard M Peek; Timothy L Cover; M Kay Washington; Keith T Wilson; D Brent Polk
Journal:  Gastroenterology       Date:  2009-01-01       Impact factor: 22.682

8.  Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.

Authors:  Li-Jing Zhang; Shi-Yan Wang; Xiao-Hui Huo; Zhen-Long Zhu; Jian-Kun Chu; Jin-Cheng Ma; Dong-Sheng Cui; Ping Gu; Zeng-Ren Zhao; Ming-Wei Wang; Jun Yu
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

9.  Helicobacter pylori promotes apoptosis, activates cyclooxygenase (COX)-2 and inhibits heat shock protein HSP70 in gastric cancer epithelial cells.

Authors:  Aneta Targosz; Tomasz Brzozowski; Piotr Pierzchalski; Urszula Szczyrk; Agata Ptak-Belowska; Stanislaw Jan Konturek; Wieslaw Pawlik
Journal:  Inflamm Res       Date:  2012-05-19       Impact factor: 4.575

10.  Assessment of Helicobacter pylori eradication in patients on NSAID treatment.

Authors:  Harald E Vonkeman; Htji Deleest; Mafj van Delaar; J Vanbaarlen; Kss Steen; Wf Lems; Jwj Bijlsma; Ej Kuipers; Hhml Houben; M Janssen; Bac Dijkmans
Journal:  BMC Gastroenterol       Date:  2012-09-24       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.